Table 6 Additional disease gene expression profiling experiments
From: iRDA: a new filter towards predictive, stable, and enriched candidate genes
Disease | Class | Samples | Genes | IR | Source | GEO |
|---|---|---|---|---|---|---|
A. Multiple Myeloma (MM) | Lytic lesion: N/Y | 173 (36/137) | 12,625 | 3.81 | (Tian et al., 2003 [60]) | GSE755 |
B. Marfan Syndrome (MS) | Control/case | 101 (41/60) | 4132 | 1.46 | (Yao et al., 2007 [61]) | GSE8759 |
C. HIV Infection (HIV) | Negative/positive | 166 (41/125) | 4776 | 3.05 | (Morse et al., 2012 [62]) | GSE30310 |
D. Neurodegeneration (AD) | VH/AD11 | 119 (59/60) | 16,515 | 1.02 | (D’Onofrio et al., 2011 [63]) | GSE63617 |